Aardvark Therapeutics Inc (AARD) PT Lowered to $19 at RBC Capital
Tweet Send to a Friend
(Updated - August 14, 2025 10:48 AM EDT)
RBC Capital analyst Brian Abrahams lowered the price target on Aardvark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams lowered the price target on Aardvark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
